M&A Deal Summary |
|
|---|---|
| Date | 2007-12-05 |
| Target | Lareq Pharma SL |
| Sector | Life Science |
| Buyer(s) | Apotex |
| Deal Type | Divestiture |
SEARCH BY
Apotex is an independent pharmaceutical company committed to R&D, manufacturing, and distributing a broad range of high-quality, affordable medicines to patients, healthcare providers, payers, and governments worldwide. Apotex was founded in 1974 and is based in Toronto, Ontario.
| DEAL STATS | # |
|---|---|
| Overall | 2 of 4 |
| Sector: Life Science M&A | 2 of 4 |
| Type: Divestiture M&A Deals | 2 of 3 |
| Country: Spain M&A | 1 of 1 |
| Year: 2007 M&A | 2 of 2 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2007-11-15 |
Topgen E.S.V.
Brussels, Belgium Topgen, headquartered in Brussels, is a generic pharmaceutical company. The Company has approximately 30 generic registrations and a nationwide sales force that reaches over 4,000 doctors and 3,000 pharmacies. |
Buy | - |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2012-03-30 |
Aveva
Miramar, Florida, United States AVEVA is a transdermal drug delivery provider. The company provides pharmaceutical partners with fully integrated, controlled-release transdermal products that fulfill unmet market needs or supply high-quality, affordable brand equivalents. Aveva was founded in 1991 and is based in Miramar, Florida. |
Buy | - |
